Incidence of gastrointestinal bleeding in patients with cardiovascular disease: buffered aspirin versus enteric-coated aspirin

References

• Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101(10):1206–18.
   PubMed Web of Science ®Google Scholar
• Weiss HJ, Aledort LM. Impaired platelet-connective-tissue reaction in man after aspirin ingestion. Lancet 1967;2(7514):495–7.
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324(7329):71–86.
   PubMedGoogle Scholar
• Weil J, Colin-Jones D, Langman M, Lawson D, Logan R, Murphy M, Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ 1995;310(6983):827–30.
   PubMedGoogle Scholar
• Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case–control study. BMJ 2006;333(7571):726.
   PubMedGoogle Scholar
• Laine L. Review article: gastrointestinal bleeding with low-dose aspirin – what's the risk? Aliment Pharmacol Ther 2006;24(6):897–908.
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Effects of very low dose daily, long-term aspirin therapy on gastric, duodenal, and rectal prostaglandin levels and on mucosal injury in healthy humans. Gastroenterology 1999;117(1):17–25.
   PubMed Web of Science ®Google Scholar
• Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997;112(3):1000–16.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6(11):1279–82.
   PubMed Web of Science ®Google Scholar
• Ng FH, Wong SY, Lam KF, Chang CM, Lau YK, Chu WM, Gastrointestinal bleeding in patients receiving a combination of aspirin, clopidogrel, and enoxaparin in acute coronary syndrome. Am J Gastroenterol 2008;103(4):865–71.
   PubMed Web of Science ®Google Scholar
• Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009;79(1):44–51.
   PubMed Web of Science ®Google Scholar
• Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 2010;45(3):292–8.
   PubMed Web of Science ®Google Scholar
• Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998;351(9098):233–41.
   PubMed Web of Science ®Google Scholar
• Banoob DW, McCloskey WW, Webster W. Risk of gastric injury with enteric- versus nonenteric-coated aspirin. Ann Pharmacother 2002;36(1):163–6.
   PubMed Web of Science ®Google Scholar
• Lanza FL, Royer GL Jr, Nelson RS. Endoscopic evaluation of the effects of aspirin, buffered aspirin, and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980;303(3):136–8.
   PubMed Web of Science ®Google Scholar
• Petroski D. Endoscopic comparison of three aspirin preparations and placebo. Clin Ther 1993;15(2):314–20.
   PubMed Web of Science ®Google Scholar
• Kelly JP, Kaufman DW, Jurgelon JM, Sheehan J, Koff RS, Shapiro S. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet 1996;348(9039):1413–16.
   PubMed Web of Science ®Google Scholar
• Sorensen HT, Mellemkjaer L, Blot WJ, Nielsen GL, Steffensen FH, McLaughlin JK, Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000;95(9):2218–24.
   PubMed Web of Science ®Google Scholar
• Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF, Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002;55(7):775–9.
   PubMed Web of Science ®Google Scholar
• Sung JJ, Lau JY, Ching JY, Wu JC, Lee YT, Chiu PW, Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 2010;152(1):1–9.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Yamamoto H, Kita H, Sunada K, Sato H, Yano T, Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol 2005;11(31):4861–4.
   PubMed Web of Science ®Google Scholar
• Yen HH, Chen YY, Soon MS. The role of double-balloon endoscopy in NSAID enteropathy. Gastrointest Endosc 2006;64(6):1035–6.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Kudo T, Esaki M, Yano T, Yamamoto H, Sakamoto C, Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008;43(4):490–6.
   PubMed Web of Science ®Google Scholar
• Slattery J, Warlow CP, Shorrock CJ, Langman MJ. Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin – analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995;37(4):509–11.
   Google Scholar
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 1996;348(9038):1329–39.
   Google Scholar